mucopolysaccharidoses: current therapies offer hope, but more effective treatments are needed
Published 5 years ago • 84 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
5:10
current treatment options for hurler syndrome (mucopolysaccharidosis type i or mps i)
-
6:14
approved and emerging therapies for mucopolysaccharidoses (mps)
-
11:46
mucopolysaccharidoses and mucolipidoses explained
-
9:15
gene therapy (rgx-111) to treat mucopolysaccharidosis type i (mps i)
-
5:33
mucopolysaccharidosis type i: overview, diagnosis challenges, treatments, and emerging therapies
-
12:14
overview of the mucopolysaccharidoses
-
2:44
overview of mucopolysaccharidosis type i (mps i)
-
2:19
phase 1/2 study evaluating sobi003 for treatment of mucopolysaccharidosis type iiia (mps iiia)
-
31:17
webinar: covid-19 and mps patients
-
3:24
mucopolysaccharidosis conditions explained
-
4:01
premjit amornchai: moru biosafety level 3 and melioidosis in thailand
-
16:18
current clinical trials for mps i and ii
-
5:35
mucopolysaccharide storage disease type i: hurler, hurler-scheie, and scheie syndromes
-
2:55
mucopolysaccharidosis type iv morquio disease
-
28:45
2020 family conference - mucolipidosis research updates
-
13:23
mucopolysaccharidosis | clinical features of mucopolysaccharidosis | biochemistry
-
3:26
mucopolysaccharidosis type vii (mps vii or sly syndrome)
-
5:10
mucopolysaccharidosis type vi (mps vi or maroteaux-lamy syndrome)
-
17:17
justin o'grady│rapid metagenomic diagnosis of hospital acquired pneumonia